Inhibitors of COTL1 typically belong to the broader class of actin cytoskeleton modulators. These inhibitors affect the actin cytoskeleton's structure and dynamics, which subsequently influence the interactions and activities of proteins like COTL1. Actin cytoskeleton inhibitors can be broadly categorized into several groups, each with unique mechanisms of action.
One group includes inhibitors that directly bind to actin monomers or filaments, altering their polymerization or stability. These compounds can interfere with COTL1's ability to bind to actin filaments or modulate their organization. Another group comprises compounds that target upstream regulators of the actin cytoskeleton, such as Rho GTPases or kinases. By affecting these regulators, these inhibitors indirectly influence the dynamics of actin, which in turn can impact COTL1's function. Additionally, some inhibitors focus on proteins that interact with COTL1 or actin-binding proteins, altering their interactions and cellular roles. While these inhibitors do not directly target COTL1, they can serve as valuable tools to investigate COTL1's involvement in actin-dependent cellular processes. Researchers often choose inhibitors based on their specific research goals, as the diverse mechanisms of action of actin cytoskeleton inhibitors can offer valuable insights into the intricate regulatory networks governing cellular organization and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Binds actin monomers to prevent polymerization into filaments. May disrupt COTL1's interaction with F-actin, modifying its cellular role. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Severs actin filaments and prevents polymerization. This may weaken COTL1's association with actin structures, changing its activity. | ||||||
Zileuton | 111406-87-2 | sc-204417 sc-204417A sc-204417B sc-204417C | 10 mg 50 mg 1 g 75 g | $82.00 $301.00 $362.00 $1229.00 | 8 | |
5-lipoxygenase inhibitor, reducing leukotriene production. By inhibiting 5-lipoxygenase, it might affect COTL1's interaction with the enzyme, thus potentially altering leukotriene biosynthesis. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $107.00 $376.00 $2147.00 | 3 | |
Inhibits 5-lipoxygenase, reducing the synthesis of leukotrienes. This could impact COTL1's known interaction with 5-lipoxygenase. | ||||||
MK-886 sodium salt | 118427-55-7 | sc-200608B sc-200608 sc-200608A | 1 mg 5 mg 25 mg | $46.00 $93.00 $371.00 | 3 | |
Inhibits 5-lipoxygenase-activating protein (FLAP), indirectly reducing 5-lipoxygenase activity. This could influence COTL1's interaction dynamics with 5-lipoxygenase. | ||||||